Setmelanotide
RM-493-029
Phase 1 small_molecule completed
Quick answer
Setmelanotide for Renal Insufficiency is a Phase 1 program (small_molecule) at RHYTHM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RHYTHM PHARMACEUTICALS, INC.
- Indication
- Renal Insufficiency
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed